These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24789946)

  • 1. Disease stratification in idiopathic pulmonary fibrosis: the dawn of a new era?
    Maher TM
    Eur Respir J; 2014 May; 43(5):1233-6. PubMed ID: 24789946
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in the study of biomarkers of idiopathic pulmonary fibrosis in Japan.
    Huang H; Peng X; Nakajima J
    Biosci Trends; 2013 Aug; 7(4):172-7. PubMed ID: 24056167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in idiopathic pulmonary fibrosis: picking the winners for trials.
    Crooks MG; Hart SP
    Lancet Respir Med; 2015 Jun; 3(6):421-2. PubMed ID: 25770675
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk prediction in idiopathic pulmonary fibrosis.
    Ley B; Collard HR
    Am J Respir Crit Care Med; 2012 Jan; 185(1):6-7. PubMed ID: 22210784
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrocytes as potential biomarkers in idiopathic pulmonary fibrosis.
    Moore BB
    Am J Respir Crit Care Med; 2009 Apr; 179(7):524-5. PubMed ID: 19318541
    [No Abstract]   [Full Text] [Related]  

  • 6. [Protein C system in patients with idiopathic pulmonary fibrosis--preliminary report].
    Kiziewicz A; Zekanowska E; Cieśliński K; Góralczyk K
    Pneumonol Alergol Pol; 2008; 76(4):225-8. PubMed ID: 18785126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of anti-periplakin auto-antibodies during idiopathic pulmonary fibrosis.
    Mignot S; Taille C; Besnard V; Crestani B; Chollet-Martin S
    Clin Chim Acta; 2014 Jun; 433():242. PubMed ID: 24685571
    [No Abstract]   [Full Text] [Related]  

  • 8. Author's reply to "detection of anti-periplakin autoantibodies during idiopathic pulmonary fibrosis" by Taillé et al.
    Muro Y; Tsuchisaka A; Ishii N; Hashimoto T; Sugiura K; Akiyama M
    Clin Chim Acta; 2014 Jun; 433():194. PubMed ID: 24685575
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential role of endothelin-1 in pulmonary fibrosis: from the bench to the clinic.
    Barlo NP; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
    Am J Respir Cell Mol Biol; 2010 May; 42(5):633. PubMed ID: 20393073
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma proteins for risk prediction in idiopathic pulmonary fibrosis.
    Richards TJ; Kaminski N; Gibson KF
    Am J Respir Crit Care Med; 2012 Jun; 185(12):1329-30. PubMed ID: 22707740
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood Biomarkers in Idiopathic Pulmonary Fibrosis.
    Guiot J; Moermans C; Henket M; Corhay JL; Louis R
    Lung; 2017 Jun; 195(3):273-280. PubMed ID: 28353114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis - a potential biomarker role for LysoPC.
    Rindlisbacher B; Schmid C; Geiser T; Bovet C; Funke-Chambour M
    Respir Res; 2018 Jan; 19(1):7. PubMed ID: 29321022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.
    Yan F; Wen Z; Wang R; Luo W; Du Y; Wang W; Chen X
    BMC Pulm Med; 2017 Dec; 17(1):174. PubMed ID: 29212488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosis.
    de Brouwer B; Drent M; van den Ouweland JMW; Wijnen PA; van Moorsel CHM; Bekers O; Grutters JC; White ES; Janssen R
    Respir Res; 2018 Mar; 19(1):45. PubMed ID: 29558926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current progression in the biomarkers of idiopathic pulmonary fibrosis].
    Wang XF; Zhang YW; Cai HR
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Nov; 36(11):841-3. PubMed ID: 24507397
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias.
    White ES; Xia M; Murray S; Dyal R; Flaherty CM; Flaherty KR; Moore BB; Cheng L; Doyle TJ; Villalba J; Dellaripa PF; Rosas IO; Kurtis JD; Martinez FJ
    Am J Respir Crit Care Med; 2016 Nov; 194(10):1242-1251. PubMed ID: 27149370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of fibrocytes in peripheral blood.
    Bournazos S; Fahim A; Hart SP
    Am J Respir Crit Care Med; 2009 Dec; 180(12):1279; author reply 1279. PubMed ID: 19949240
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum biomarkers in idiopathic pulmonary fibrosis.
    van den Blink B; Wijsenbeek MS; Hoogsteden HC
    Pulm Pharmacol Ther; 2010 Dec; 23(6):515-20. PubMed ID: 20708704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MFAP4: a candidate biomarker for hepatic and pulmonary fibrosis?
    Mölleken C; Poschmann G; Bonella F; Costabel U; Sitek B; Stühler K; Meyer HE; Schmiegel WH; Marcussen N; Helmer M; Nielsen O; Hansen S; Schlosser A; Holmskov U; Sorensen GL
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Mar; 33(1):41-50. PubMed ID: 27055835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications.
    Nair GB; Matela A; Kurbanov D; Raghu G
    Expert Rev Respir Med; 2016 Jun; 10(6):699-711. PubMed ID: 27094006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.